Tapinarof Cream 1% Once Daily for Plaque Psoriasis: Pooled Efficacy from Three Phase 3 Trials

Main Article Content

Linda Stein Gold
Mark Lebwohl
Robert Bissonnette
Bruce Strober
Anna M Tallman
Philip M Brown
Stephen C Piscitelli
David S Rubenstein

Keywords

tapinarof, psoriasis, efficacy, phase 3 trial

Abstract

N/A

References

1. Dermavant Sciences. VTAMA (tapinarof) cream, 1%: US prescribing information. 2022. https://www.vtama.com/docs/DMVT_VTAMA_PI.pdf. Accessed July 2022.

2. Lebwohl M, et al. N Engl J Med. 2021;385:2219–2229.

3. Strober B, et al. J Am Acad Dermatol. 2022. https://doi.org/10.1016/j.jaad.2022.06.1171.

Most read articles by the same author(s)

<< < 5 6 7 8 9 10 11 12 13 14 > >>